APO Research
Talk to an analyst

APO RESEARCH · REPORT

GMP Lentivirus Production Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global GMP Lentivirus Production Service Market Analysis and Forecast 2026-2032

21 December 2025192 pages

Choose your research edition.

Industry ResearchGMP Lentivirus Production Service Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal GMP Lentivirus Production Service Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal GMP Lentivirus Production Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal GMP Lentivirus Production Service Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal GMP Lentivirus Production Service Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global GMP Lentivirus Production Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for GMP Lentivirus Production Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for GMP Lentivirus Production Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for GMP Lentivirus Production Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for GMP Lentivirus Production Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of GMP Lentivirus Production Service include AGC Biologics, Biocompare, BPS Bioscience, Charles River Laboratories, Creative Biogene, Hillgene Biopharma, OXB, ProBio CDMO and ProBioGen AG, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for GMP Lentivirus Production Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of GMP Lentivirus Production Service, also provides the revenue of main regions and countries. Of the upcoming market potential for GMP Lentivirus Production Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the GMP Lentivirus Production Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global GMP Lentivirus Production Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for GMP Lentivirus Production Service revenue, projected growth trends, production technology, application and end-user industry.

GMP Lentivirus Production Service Segment by Company

AGC Biologics

Biocompare

BPS Bioscience

Charles River Laboratories

Creative Biogene

Hillgene Biopharma

OXB

ProBio CDMO

ProBioGen AG

Revvity

SK pharmteco

Thermo Fisher Scientific

VectorBuilder

VIVEbiotech

GMP Lentivirus Production Service Segment by Type

R&D and Preclinical Service

Early Clinical (Phase I/II) Service

Late Clinical and Commercial (Phase III/Launch) Service

GMP Lentivirus Production Service Segment by Application

CAR-T Therapy

Vaccine Development

Gene Editing

Others

GMP Lentivirus Production Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GMP Lentivirus Production Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of GMP Lentivirus Production Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GMP Lentivirus Production Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of GMP Lentivirus Production Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of GMP Lentivirus Production Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, GMP Lentivirus Production Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global GMP Lentivirus Production Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. R&D and Preclinical Service Major Player Table 3. Early Clinical (Phase I/II) Service Major Player Table 4. Late Clinical and Commercial (Phase III/Launch) Service Major Player Table 5. Global GMP Lentivirus Production Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. CAR-T Therapy Major Player Table 7. Vaccine Development Major Player Table 8. Gene Editing Major Player Table 9. Others Major Player Table 10. GMP Lentivirus Production Service Industry Trends Table 11. GMP Lentivirus Production Service Industry Drivers Table 12. GMP Lentivirus Production Service Industry Opportunities and Challenges Table 13. GMP Lentivirus Production Service Industry Restraints Table 14. Global GMP Lentivirus Production Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global GMP Lentivirus Production Service Market Size by Region (2021-2026) & (US$ Million) Table 16. Global GMP Lentivirus Production Service Market Share by Region (2021-2026) Table 17. Global GMP Lentivirus Production Service Market Size by Region (2027-2032) & (US$ Million) Table 18. Global GMP Lentivirus Production Service Market Share by Region (2027-2032) Table 19. Global GMP Lentivirus Production Service Revenue by Players (US$ Million) & (2021-2026) Table 20. Global GMP Lentivirus Production Service Revenue Market Share by Players (2021-2026) Table 21. Global GMP Lentivirus Production Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global GMP Lentivirus Production Service Key Players Headquarters & Area Served Table 23. Global GMP Lentivirus Production Service Players, Product Type & Application Table 24. Global GMP Lentivirus Production Service Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global GMP Lentivirus Production Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global GMP Lentivirus Production Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global GMP Lentivirus Production Service Revenue by Type (2021-2026) & (US$ Million) Table 29. Global GMP Lentivirus Production Service Revenue by Type (2027-2032) & (US$ Million) Table 30. Global GMP Lentivirus Production Service Revenue Market Share by Type (2021-2026) Table 31. Global GMP Lentivirus Production Service Revenue Market Share by Type (2027-2032) Table 32. Global GMP Lentivirus Production Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global GMP Lentivirus Production Service Revenue by Application (2021-2026) & (US$ Million) Table 34. Global GMP Lentivirus Production Service Revenue by Application (2027-2032) & (US$ Million) Table 35. Global GMP Lentivirus Production Service Revenue Market Share by Application (2021-2026) Table 36. Global GMP Lentivirus Production Service Revenue Market Share by Application (2027-2032) Table 37. AGC Biologics Company Information Table 38. AGC Biologics Business Overview Table 39. AGC Biologics GMP Lentivirus Production Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. AGC Biologics GMP Lentivirus Production Service Product Portfolio Table 41. AGC Biologics Recent Development Table 42. Biocompare Company Information Table 43. Biocompare Business Overview Table 44. Biocompare GMP Lentivirus Production Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Biocompare GMP Lentivirus Production Service Product Portfolio Table 46. Biocompare Recent Development Table 47. BPS Bioscience Company Information Table 48. BPS Bioscience Business Overview Table 49. BPS Bioscience GMP Lentivirus Production Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. BPS Bioscience GMP Lentivirus Production Service Product Portfolio Table 51. BPS Bioscience Recent Development Table 52. Charles River Laboratories Company Information Table 53. Charles River Laboratories Business Overview Table 54. Charles River Laboratories GMP Lentivirus Production Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Charles River Laboratories GMP Lentivirus Production Service Product Portfolio Table 56. Charles River Laboratories Recent Development Table 57. Creative Biogene Company Information Table 58. Creative Biogene Business Overview Table 59. Creative Biogene GMP Lentivirus Production Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Creative Biogene GMP Lentivirus Production Service Product Portfolio Table 61. Creative Biogene Recent Development Table 62. Hillgene Biopharma Company Information Table 63. Hillgene Biopharma Business Overview Table 64. Hillgene Biopharma GMP Lentivirus Production Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Hillgene Biopharma GMP Lentivirus Production Service Product Portfolio Table 66. Hillgene Biopharma Recent Development Table 67. OXB Company Information Table 68. OXB Business Overview Table 69. OXB GMP Lentivirus Production Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. OXB GMP Lentivirus Production Service Product Portfolio Table 71. OXB Recent Development Table 72. ProBio CDMO Company Information Table 73. ProBio CDMO Business Overview Table 74. ProBio CDMO GMP Lentivirus Production Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. ProBio CDMO GMP Lentivirus Production Service Product Portfolio Table 76. ProBio CDMO Recent Development Table 77. ProBioGen AG Company Information Table 78. ProBioGen AG Business Overview Table 79. ProBioGen AG GMP Lentivirus Production Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. ProBioGen AG GMP Lentivirus Production Service Product Portfolio Table 81. ProBioGen AG Recent Development Table 82. Revvity Company Information Table 83. Revvity Business Overview Table 84. Revvity GMP Lentivirus Production Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Revvity GMP Lentivirus Production Service Product Portfolio Table 86. Revvity Recent Development Table 87. SK pharmteco Company Information Table 88. SK pharmteco Business Overview Table 89. SK pharmteco GMP Lentivirus Production Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. SK pharmteco GMP Lentivirus Production Service Product Portfolio Table 91. SK pharmteco Recent Development Table 92. Thermo Fisher Scientific Company Information Table 93. Thermo Fisher Scientific Business Overview Table 94. Thermo Fisher Scientific GMP Lentivirus Production Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Thermo Fisher Scientific GMP Lentivirus Production Service Product Portfolio Table 96. Thermo Fisher Scientific Recent Development Table 97. VectorBuilder Company Information Table 98. VectorBuilder Business Overview Table 99. VectorBuilder GMP Lentivirus Production Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. VectorBuilder GMP Lentivirus Production Service Product Portfolio Table 101. VectorBuilder Recent Development Table 102. VIVEbiotech Company Information Table 103. VIVEbiotech Business Overview Table 104. VIVEbiotech GMP Lentivirus Production Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. VIVEbiotech GMP Lentivirus Production Service Product Portfolio Table 106. VIVEbiotech Recent Development Table 107. North America GMP Lentivirus Production Service Revenue by Type (2021-2026) & (US$ Million) Table 108. North America GMP Lentivirus Production Service Revenue by Type (2027-2032) & (US$ Million) Table 109. North America GMP Lentivirus Production Service Revenue by Application (2021-2026) & (US$ Million) Table 110. North America GMP Lentivirus Production Service Revenue by Application (2027-2032) & (US$ Million) Table 111. North America GMP Lentivirus Production Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. North America GMP Lentivirus Production Service Revenue by Country (2021-2026) & (US$ Million) Table 113. North America GMP Lentivirus Production Service Revenue by Country (US$ Million) & (2027-2032) Table 114. Europe GMP Lentivirus Production Service Revenue by Type (2021-2026) & (US$ Million) Table 115. Europe GMP Lentivirus Production Service Revenue by Type (2027-2032) & (US$ Million) Table 116. Europe GMP Lentivirus Production Service Revenue by Application (2021-2026) & (US$ Million) Table 117. Europe GMP Lentivirus Production Service Revenue by Application (2027-2032) & (US$ Million) Table 118. Europe GMP Lentivirus Production Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 119. Europe GMP Lentivirus Production Service Revenue by Country (2021-2026) & (US$ Million) Table 120. Europe GMP Lentivirus Production Service Revenue by Country (US$ Million) & (2027-2032) Table 121. China GMP Lentivirus Production Service Revenue by Type (2021-2026) & (US$ Million) Table 122. China GMP Lentivirus Production Service Revenue by Type (2027-2032) & (US$ Million) Table 123. China GMP Lentivirus Production Service Revenue by Application (2021-2026) & (US$ Million) Table 124. China GMP Lentivirus Production Service Revenue by Application (2027-2032) & (US$ Million) Table 125. Asia GMP Lentivirus Production Service Revenue by Type (2021-2026) & (US$ Million) Table 126. Asia GMP Lentivirus Production Service Revenue by Type (2027-2032) & (US$ Million) Table 127. Asia GMP Lentivirus Production Service Revenue by Application (2021-2026) & (US$ Million) Table 128. Asia GMP Lentivirus Production Service Revenue by Application (2027-2032) & (US$ Million) Table 129. Asia GMP Lentivirus Production Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 130. Asia GMP Lentivirus Production Service Revenue by Region (US$ Million) & (2021-2026) Table 131. Asia GMP Lentivirus Production Service Revenue by Region (US$ Million) & (2027-2032) Table 132. SAMEA GMP Lentivirus Production Service Revenue by Type (2021-2026) & (US$ Million) Table 133. SAMEA GMP Lentivirus Production Service Revenue by Type (2027-2032) & (US$ Million) Table 134. SAMEA GMP Lentivirus Production Service Revenue by Application (2021-2026) & (US$ Million) Table 135. SAMEA GMP Lentivirus Production Service Revenue by Application (2027-2032) & (US$ Million) Table 136. SAMEA GMP Lentivirus Production Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. SAMEA GMP Lentivirus Production Service Revenue by Country (2021-2026) & (US$ Million) Table 138. SAMEA GMP Lentivirus Production Service Revenue by Country (US$ Million) & (2027-2032) Table 139. Research Programs/Design for This Report Table 140. Authors List of This Report Table 141. Secondary Sources Table 142. Primary Sources List of Figures Figure 1. GMP Lentivirus Production Service Image Figure 2. Global GMP Lentivirus Production Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global GMP Lentivirus Production Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. R&D and Preclinical Service Image Figure 5. Early Clinical (Phase I/II) Service Image Figure 6. Late Clinical and Commercial (Phase III/Launch) Service Image Figure 7. Global GMP Lentivirus Production Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global GMP Lentivirus Production Service Market Size Share 2021 VS 2025 VS 2032 Figure 9. CAR-T Therapy Image Figure 10. Vaccine Development Image Figure 11. Gene Editing Image Figure 12. Others Image Figure 13. Global GMP Lentivirus Production Service Market Size (US$ Million) & (2021-2032) Figure 14. Global GMP Lentivirus Production Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global GMP Lentivirus Production Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global GMP Lentivirus Production Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global GMP Lentivirus Production Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global GMP Lentivirus Production Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global GMP Lentivirus Production Service Revenue Market Share by Type (2021-2032) Figure 21. Global GMP Lentivirus Production Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global GMP Lentivirus Production Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global GMP Lentivirus Production Service Revenue Market Share by Application (2021-2032) Figure 24. North America GMP Lentivirus Production Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America GMP Lentivirus Production Service Revenue Share by Type (2021-2032) Figure 26. North America GMP Lentivirus Production Service Revenue Share by Application (2021-2032) Figure 27. North America GMP Lentivirus Production Service Revenue Share by Country (2021-2032) Figure 28. United States GMP Lentivirus Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada GMP Lentivirus Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico GMP Lentivirus Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe GMP Lentivirus Production Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe GMP Lentivirus Production Service Revenue Share by Type (2021-2032) Figure 33. Europe GMP Lentivirus Production Service Revenue Share by Application (2021-2032) Figure 34. Europe GMP Lentivirus Production Service Revenue Share by Country (2021-2032) Figure 35. Germany GMP Lentivirus Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France GMP Lentivirus Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. GMP Lentivirus Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy GMP Lentivirus Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain GMP Lentivirus Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia GMP Lentivirus Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands GMP Lentivirus Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries GMP Lentivirus Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China GMP Lentivirus Production Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China GMP Lentivirus Production Service Revenue Share by Type (2021-2032) Figure 45. China GMP Lentivirus Production Service Revenue Share by Application (2021-2032) Figure 46. Asia GMP Lentivirus Production Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia GMP Lentivirus Production Service Revenue Share by Type (2021-2032) Figure 48. Asia GMP Lentivirus Production Service Revenue Share by Application (2021-2032) Figure 49. Asia GMP Lentivirus Production Service Revenue Share by Region (2021-2032) Figure 50. Japan GMP Lentivirus Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea GMP Lentivirus Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India GMP Lentivirus Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia GMP Lentivirus Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan GMP Lentivirus Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia GMP Lentivirus Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA GMP Lentivirus Production Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA GMP Lentivirus Production Service Revenue Share by Type (2021-2032) Figure 58. SAMEA GMP Lentivirus Production Service Revenue Share by Application (2021-2032) Figure 59. SAMEA GMP Lentivirus Production Service Revenue Share by Country (2021-2032) Figure 60. Brazil GMP Lentivirus Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina GMP Lentivirus Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile GMP Lentivirus Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia GMP Lentivirus Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru GMP Lentivirus Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia GMP Lentivirus Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel GMP Lentivirus Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE GMP Lentivirus Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey GMP Lentivirus Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran GMP Lentivirus Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt GMP Lentivirus Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • R&D and Preclinical Service
  • Early Clinical (Phase I/II) Service
  • Late Clinical and Commercial (Phase III/Launch) Service
Applications
  • CAR-T Therapy
  • Vaccine Development
  • Gene Editing
  • Others
Companies covered
  • AGC Biologics
  • Biocompare
  • BPS Bioscience
  • Charles River Laboratories
  • Creative Biogene
  • Hillgene Biopharma
  • OXB
  • ProBio CDMO
  • ProBioGen AG
  • Revvity
  • SK pharmteco
  • Thermo Fisher Scientific
  • VectorBuilder
  • VIVEbiotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 GMP Lentivirus Production Service Market by Type
  3. 1.2.1 Global GMP Lentivirus Production Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 R&D and Preclinical Service
  5. 1.2.3 Early Clinical (Phase I/II) Service
  6. 1.2.4 Late Clinical and Commercial (Phase III/Launch) Service
  7. 1.3 GMP Lentivirus Production Service Market by Application
  8. 1.3.1 Global GMP Lentivirus Production Service Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 CAR-T Therapy
  10. 1.3.3 Vaccine Development
  11. 1.3.4 Gene Editing
  12. 1.3.5 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 GMP Lentivirus Production Service Market Dynamics
  1. 2.1 GMP Lentivirus Production Service Industry Trends
  2. 2.2 GMP Lentivirus Production Service Industry Drivers
  3. 2.3 GMP Lentivirus Production Service Industry Opportunities and Challenges
  4. 2.4 GMP Lentivirus Production Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global GMP Lentivirus Production Service Market Perspective (2021-2032)
  2. 3.2 Global GMP Lentivirus Production Service Growth Trends by Region
  3. 3.2.1 Global GMP Lentivirus Production Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global GMP Lentivirus Production Service Market Size by Region (2021-2026)
  5. 3.2.3 Global GMP Lentivirus Production Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global GMP Lentivirus Production Service Revenue by Players
  2. 4.1.1 Global GMP Lentivirus Production Service Revenue by Players (2021-2026)
  3. 4.1.2 Global GMP Lentivirus Production Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global GMP Lentivirus Production Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global GMP Lentivirus Production Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global GMP Lentivirus Production Service Key Players Headquarters & Area Served
  7. 4.4 Global GMP Lentivirus Production Service Players, Product Type & Application
  8. 4.5 Global GMP Lentivirus Production Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global GMP Lentivirus Production Service Market CR5 and HHI
  11. 4.6.3 2025 GMP Lentivirus Production Service Tier 1, Tier 2, and Tier 3
5 GMP Lentivirus Production Service Market Size by Type
  1. 5.1 Global GMP Lentivirus Production Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global GMP Lentivirus Production Service Revenue by Type (2021-2032)
  3. 5.3 Global GMP Lentivirus Production Service Revenue Market Share by Type (2021-2032)
6 GMP Lentivirus Production Service Market Size by Application
  1. 6.1 Global GMP Lentivirus Production Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global GMP Lentivirus Production Service Revenue by Application (2021-2032)
  3. 6.3 Global GMP Lentivirus Production Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 AGC Biologics
  2. 7.1.1 AGC Biologics Company Information
  3. 7.1.2 AGC Biologics Business Overview
  4. 7.1.3 AGC Biologics GMP Lentivirus Production Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 AGC Biologics GMP Lentivirus Production Service Product Portfolio
  6. 7.1.5 AGC Biologics Recent Developments
  7. 7.2 Biocompare
  8. 7.2.1 Biocompare Company Information
  9. 7.2.2 Biocompare Business Overview
  10. 7.2.3 Biocompare GMP Lentivirus Production Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Biocompare GMP Lentivirus Production Service Product Portfolio
  12. 7.2.5 Biocompare Recent Developments
  13. 7.3 BPS Bioscience
  14. 7.3.1 BPS Bioscience Company Information
  15. 7.3.2 BPS Bioscience Business Overview
  16. 7.3.3 BPS Bioscience GMP Lentivirus Production Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 BPS Bioscience GMP Lentivirus Production Service Product Portfolio
  18. 7.3.5 BPS Bioscience Recent Developments
  19. 7.4 Charles River Laboratories
  20. 7.4.1 Charles River Laboratories Company Information
  21. 7.4.2 Charles River Laboratories Business Overview
  22. 7.4.3 Charles River Laboratories GMP Lentivirus Production Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Charles River Laboratories GMP Lentivirus Production Service Product Portfolio
  24. 7.4.5 Charles River Laboratories Recent Developments
  25. 7.5 Creative Biogene
  26. 7.5.1 Creative Biogene Company Information
  27. 7.5.2 Creative Biogene Business Overview
  28. 7.5.3 Creative Biogene GMP Lentivirus Production Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Creative Biogene GMP Lentivirus Production Service Product Portfolio
  30. 7.5.5 Creative Biogene Recent Developments
  31. 7.6 Hillgene Biopharma
  32. 7.6.1 Hillgene Biopharma Company Information
  33. 7.6.2 Hillgene Biopharma Business Overview
  34. 7.6.3 Hillgene Biopharma GMP Lentivirus Production Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Hillgene Biopharma GMP Lentivirus Production Service Product Portfolio
  36. 7.6.5 Hillgene Biopharma Recent Developments
  37. 7.7 OXB
  38. 7.7.1 OXB Company Information
  39. 7.7.2 OXB Business Overview
  40. 7.7.3 OXB GMP Lentivirus Production Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 OXB GMP Lentivirus Production Service Product Portfolio
  42. 7.7.5 OXB Recent Developments
  43. 7.8 ProBio CDMO
  44. 7.8.1 ProBio CDMO Company Information
  45. 7.8.2 ProBio CDMO Business Overview
  46. 7.8.3 ProBio CDMO GMP Lentivirus Production Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 ProBio CDMO GMP Lentivirus Production Service Product Portfolio
  48. 7.8.5 ProBio CDMO Recent Developments
  49. 7.9 ProBioGen AG
  50. 7.9.1 ProBioGen AG Company Information
  51. 7.9.2 ProBioGen AG Business Overview
  52. 7.9.3 ProBioGen AG GMP Lentivirus Production Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 ProBioGen AG GMP Lentivirus Production Service Product Portfolio
  54. 7.9.5 ProBioGen AG Recent Developments
  55. 7.10 Revvity
  56. 7.10.1 Revvity Company Information
  57. 7.10.2 Revvity Business Overview
  58. 7.10.3 Revvity GMP Lentivirus Production Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Revvity GMP Lentivirus Production Service Product Portfolio
  60. 7.10.5 Revvity Recent Developments
  61. 7.11 SK pharmteco
  62. 7.11.1 SK pharmteco Company Information
  63. 7.11.2 SK pharmteco Business Overview
  64. 7.11.3 SK pharmteco GMP Lentivirus Production Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 SK pharmteco GMP Lentivirus Production Service Product Portfolio
  66. 7.11.5 SK pharmteco Recent Developments
  67. 7.12 Thermo Fisher Scientific
  68. 7.12.1 Thermo Fisher Scientific Company Information
  69. 7.12.2 Thermo Fisher Scientific Business Overview
  70. 7.12.3 Thermo Fisher Scientific GMP Lentivirus Production Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Thermo Fisher Scientific GMP Lentivirus Production Service Product Portfolio
  72. 7.12.5 Thermo Fisher Scientific Recent Developments
  73. 7.13 VectorBuilder
  74. 7.13.1 VectorBuilder Company Information
  75. 7.13.2 VectorBuilder Business Overview
  76. 7.13.3 VectorBuilder GMP Lentivirus Production Service Revenue and Gross Margin (2021-2026)
  77. 7.13.4 VectorBuilder GMP Lentivirus Production Service Product Portfolio
  78. 7.13.5 VectorBuilder Recent Developments
  79. 7.14 VIVEbiotech
  80. 7.14.1 VIVEbiotech Company Information
  81. 7.14.2 VIVEbiotech Business Overview
  82. 7.14.3 VIVEbiotech GMP Lentivirus Production Service Revenue and Gross Margin (2021-2026)
  83. 7.14.4 VIVEbiotech GMP Lentivirus Production Service Product Portfolio
  84. 7.14.5 VIVEbiotech Recent Developments
8 North America
  1. 8.1 North America GMP Lentivirus Production Service Revenue (2021-2032)
  2. 8.2 North America GMP Lentivirus Production Service Revenue by Type (2021-2032)
  3. 8.2.1 North America GMP Lentivirus Production Service Revenue by Type (2021-2026)
  4. 8.2.2 North America GMP Lentivirus Production Service Revenue by Type (2027-2032)
  5. 8.3 North America GMP Lentivirus Production Service Revenue Share by Type (2021-2032)
  6. 8.4 North America GMP Lentivirus Production Service Revenue by Application (2021-2032)
  7. 8.4.1 North America GMP Lentivirus Production Service Revenue by Application (2021-2026)
  8. 8.4.2 North America GMP Lentivirus Production Service Revenue by Application (2027-2032)
  9. 8.5 North America GMP Lentivirus Production Service Revenue Share by Application (2021-2032)
  10. 8.6 North America GMP Lentivirus Production Service Revenue by Country
  11. 8.6.1 North America GMP Lentivirus Production Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America GMP Lentivirus Production Service Revenue by Country (2021-2026)
  13. 8.6.3 North America GMP Lentivirus Production Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe GMP Lentivirus Production Service Revenue (2021-2032)
  2. 9.2 Europe GMP Lentivirus Production Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe GMP Lentivirus Production Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe GMP Lentivirus Production Service Revenue by Type (2027-2032)
  5. 9.3 Europe GMP Lentivirus Production Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe GMP Lentivirus Production Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe GMP Lentivirus Production Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe GMP Lentivirus Production Service Revenue by Application (2027-2032)
  9. 9.5 Europe GMP Lentivirus Production Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe GMP Lentivirus Production Service Revenue by Country
  11. 9.6.1 Europe GMP Lentivirus Production Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe GMP Lentivirus Production Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe GMP Lentivirus Production Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China GMP Lentivirus Production Service Revenue (2021-2032)
  2. 10.2 China GMP Lentivirus Production Service Revenue by Type (2021-2032)
  3. 10.2.1 China GMP Lentivirus Production Service Revenue by Type (2021-2026)
  4. 10.2.2 China GMP Lentivirus Production Service Revenue by Type (2027-2032)
  5. 10.3 China GMP Lentivirus Production Service Revenue Share by Type (2021-2032)
  6. 10.4 China GMP Lentivirus Production Service Revenue by Application (2021-2032)
  7. 10.4.1 China GMP Lentivirus Production Service Revenue by Application (2021-2026)
  8. 10.4.2 China GMP Lentivirus Production Service Revenue by Application (2027-2032)
  9. 10.5 China GMP Lentivirus Production Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia GMP Lentivirus Production Service Revenue (2021-2032)
  2. 11.2 Asia GMP Lentivirus Production Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia GMP Lentivirus Production Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia GMP Lentivirus Production Service Revenue by Type (2027-2032)
  5. 11.3 Asia GMP Lentivirus Production Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia GMP Lentivirus Production Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia GMP Lentivirus Production Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia GMP Lentivirus Production Service Revenue by Application (2027-2032)
  9. 11.5 Asia GMP Lentivirus Production Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia GMP Lentivirus Production Service Revenue by Country
  11. 11.6.1 Asia GMP Lentivirus Production Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia GMP Lentivirus Production Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia GMP Lentivirus Production Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA GMP Lentivirus Production Service Revenue (2021-2032)
  2. 12.2 SAMEA GMP Lentivirus Production Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA GMP Lentivirus Production Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA GMP Lentivirus Production Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA GMP Lentivirus Production Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA GMP Lentivirus Production Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA GMP Lentivirus Production Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA GMP Lentivirus Production Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA GMP Lentivirus Production Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA GMP Lentivirus Production Service Revenue by Country
  11. 12.6.1 SAMEA GMP Lentivirus Production Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA GMP Lentivirus Production Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA GMP Lentivirus Production Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst